Advancing TFF For Small Scale cGMP Production With KrosFlo® RS 10 TFF Systems

Repligen has unveiled its latest advancement in tangential flow filtration (TFF) technology with the introduction of the KrosFlo® RS 10—a purpose-built, single-use TFF system engineered specifically for the demands of process development and CGMP production in cutting-edge fields such as mRNA therapeutics, gene therapies, and personalized medicine. Unlike many systems currently in use that have been repurposed from large-scale applications, the KrosFlo RS 10 is designed from the ground up to meet the unique requirements of small-scale bioprocessing.

This innovative system offers a suite of features tailored to modern biomanufacturing needs, including complete end-to-end automation and optional real-time concentration measurement, which together streamline workflows and enhance process control. Whether you're scaling up a promising therapy or refining a production protocol, the RS 10 provides the precision and flexibility needed to accelerate development and ensure consistency.

If you're looking to optimize your workflow and bring your next breakthrough therapy to market faster, it's time to explore how the KrosFlo RS 10 can transform your process.